anti-sRANKL antibody product blog
Tags: Antibody; SRANKL; Polyclonal Antibody; anti-sRANKL antibody;
The sRANKL n/a (Catalog #MBS618814) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The sRANKL (soluble RANK Ligand, Receptor Activator of NFkB Ligand) (Biotin) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s sRANKL can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot.
Dilution: ELISA: To detect msRANKL by direct ELISA (using 100ul/well antibody solution) this antibody can be used at a concentration of 0.15-0.30ug/ml. Used in conjunction with compatible secondary reagents, allows the detection of at least 0.2ng/well of recombinant msRANKL.
Western Blot: To detect msRANKL by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 mg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant msRANKL is 1.5-3.0ng/lane, under either reducing or non-reducing conditions.
Optimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the sRANKL n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Highly pure (> 98%) recombinant murine soluble RANKL
Country of Origin: USA. Reconstitution: Reconstitute to a concentration of 50ug/ml with sterile PBS solution containing 0.1% BSA, 40-50% glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing sRANKL are readily searchable from our website. Different antibodies against the same target such as sRANKL may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.